Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has announced an application for the quotation of new securities on the ASX, with 67,568 ordinary fully paid shares set to be quoted. The application, pertaining to shares issued under an employee incentive scheme, reflects the company’s latest move in the financial markets as of September 19, 2024.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
